Yan Leyfman: Episode 3 of The Translational Edge on Cancer Anticoagulation Is Now Live on Shuf
Yan Leyfman, Medical Oncologist, Co-Founder and Executive Director of MedNews Week, Medical Correspondent at OncLive, shared Jeremy Bellaiche‘s post on LinkedIn, adding:
“Episode 3 of The Translational Edge is now live on Shuf.
As oncology care becomes more personalized, one critical question remains:
Are we dosing based on evidence—or outdated assumptions?
This episode explores the evolving science of anticoagulation in cancer patients with obesity—and how aligning practice with data can directly impact outcomes.
Translating breakthroughs into impact.
Jeremy Bellaiche, Founder of Shuf, shared a post on LinkedIn:
“Excited to share the episode 3 of The Translational Edge season 2 with Yan Leyfman exclusively on Shuf !
Treating Blood Clots in Cancer Patients with Obesity: Why Dosing Finally Caught Up with Reality.”
Stay updated with Hemostasis Today.
-
Sep 30, 2026, 01:52Javed Anees: DADA2 – When a Young Stroke Is More Than a Stroke
-
Sep 30, 2026, 01:51How a Venous Thrombus Becomes Revascularized – ISTH
-
Sep 29, 2026, 22:45Victor Agunyego: Paracetamol – The Most Common Drug We Underestimate
-
Sep 29, 2026, 22:42Nova Sinclair: Advancing the Future of Hematology – Meet Our 2027 Organizing Committee
-
Sep 29, 2026, 22:41Lorenz Räber: Intracoronary Imaging in PCI – Why, When, How, and Which Modality?
-
Sep 29, 2026, 22:31Selma Turkovic: Pleased to Deliver the Opening Presentation at Kingston Hospital
-
Sep 29, 2026, 22:31Miguel Teran: Ultrasound and Simulation in Arterial Blood Sampling
-
Sep 29, 2026, 22:28Mohammad Refaei: Navigating Your Career in Hematology From Training to Practice
-
Sep 29, 2026, 22:27Matteo Foschi: 10 Clinical Pearls for Antithrombotic Therapy in Secondary Stroke Prevention